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Abstract
Copy number variations (CNVs) represent a large source of genetic variation in humans and have been increasingly studied
for disease association. A deletion polymorphism of the gene encoding the cytosolic detoxification enzyme glutathione S-
transferase theta 1 (GSTT1) has been extensively studied for cancer susceptibility (919 studies, from HuGE navigator, http://
www.hugenavigator.net/). However, clear conclusions have not been reached. Since the GSTT1 gene is located within a
genomic region of segmental duplications (SD), there may be a confounding effect from another, yet-uncharacterized CNV
at the same locus. Here we describe a previously uncharacterized 38-kilo-base (kb) long deletion polymorphism of GSTT2B
located within a 61-kb DNA inverted repeat. GSTT2B is a duplicated copy of GSTT2, the only paralogue of GSTT1 in humans.
A newly developed PCR assay revealed that a microhomology-mediated breakpoint appears to be shared among
individuals at high frequency. The GSTT2B deletion polymorphism was in strong linkage disequilibrium (LD) (D9=0.841) with
the neighboring GSTT1 deletion polymorphism in the Caucasian population. Alleles harboring a single deletion were
significantly overrepresented (p=2.22610
216), suggesting a selection against alleles with both deletions. The deletion
alleles are almost certainly the derived ones, because the GSTT2B-GSTT2-GSTT1 genes were strictly retained in chimpanzees.
Extremely low GSTT2 mRNA expression was associated with the GSTT2B deletion, suggesting an influence of the deletion on
the flanking region and loss of GSTT2 function. Genome-wide LD analysis between deletion polymorphisms further points to
the uniqueness of two deletions, because strong LD between deletion polymorphisms might be very rare in humans. These
results show a complex genomic organization and unexpected biological functions of CNVs within segmental duplications
and emphasize the importance of detailed structural characterization for disease association studies.
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Introduction
Copy number variation (CNV) is a significant source of genetic
variation in the genome of humans [1–11]. A large number of
CNVs has been identified, and span more than 10% of the human
genome in total [12], although the estimate is dependent on the
frequency of the event under consideration. The biomedical
relevance of CNVs is expected to be significant, because many
CNVs cover large genomic regions and include exons and
regulatory elements that are important for proper cellular
function. However, these CNVs are primarily identified by
indirect, array-based methods with limited resolution; defining
fine scale structure, especially for large CNVs, is just beginning at
the sequence level [9,13,14]. Without such information, it is
difficult to determine each CNV’s history, population structure,
and influence on the function of one or more genes within the
CNV and surrounding genomic regions.
CNVs are significantly enriched in the regions of segmental
duplications (SD) [6–8,10,12]. SDs are highly identical DNA
segments that map to two or more loci within the genome [15,16].
Since regions of SDs have strong positive correlations with genes
[15,17], CNVs that overlap with SDs are particularly gene-rich.
Therefore, defining the extent and breakpoint in each CNV in
regions of SD is particularly important in order to identify CNVs
that may have clinical relevance. In fact, CNVs are highly
enriched in gene classes such as defense and immune response
[1,18], suggesting a link between CNVs in SDs and human health.
However, determining the detailed structures of CNVs in SDs is
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vary substantially among individuals, any technology based on the
reference genome sequence may not be sufficient to accurately
map all CNVs. Second, single nucleotide polymorphisms (SNPs),
the most widely used markers to tag genomic locations, are not
always reliable within SDs [19,20]. Although SNP-based
methods have identified a large number of deletion polymor-
phisms successfully [1,5], this approach may not be as efficient in
SDs as within unique segments of the genome. Therefore, more
direct approaches, such as clone-based sequencing for mapping
breakpoints, and subsequent molecular assays for genotyping,
are necessary to accurately interrogate CNVs in regions of SDs
[21].
The importance of CNVs in human diseases has become
increasingly apparent [22,23]. It has long been known that DNA
rearrangements of large genomic regions play a major role in the
pathogenesis of rare genetic diseases (genomic disorders) [24–26],
and more recently, more common complex diseases such as non-
syndromic mental retardation, autism and schizophrenia [27–30].
Common deletion polymorphisms of a class of genes in cellular
detoxification, glutathion S-transferases (GSTs), have also been
known for more than a decade [31,32]. GST is a supergene family.
Each sub-family member is located in a distinct genomic region
and consists of as many as five paralogues [33]. GST gene products
catalyze the conjugation of reduced glutathione to electrophilic
centers for a wide variety of substrates [34]. The increased
solubility of the conjugated products renders them more readily
eliminated by the cell. Substrates include both xenobiotics and
endogenous compounds that are harmful to cellular macromole-
cules. Based on the hypothesis that lack of GST may cause
reduced levels of cellular detoxification, and thus predispose
individuals to common diseases such as cancer, previously defined
null alleles (deletion polymorphisms) have been subject to
extensive disease-association studies (1230 published studies,
information obtained from HuGE Navigator). However, to date,
the reports contain conflicting results [35–38]. One possible
explanation for the conflict could be that due to extensive
segmental duplications in the genomic loci of GST family
members, there are other, yet-uncharacterized null alleles that
may impact the results.
In this study, using DNA samples from blood, lymphoblastoid
cell lines, HapMap populations, and chimpanzees; and RNA from
primary fibroblasts and cancer cell lines, we conducted a
systematic genetic, gene expression and evolutionary analysis for
a previously uncharacterized large deletion polymorphism located
at chromosome 22q13, a genomic region with a 61 kilo-base (kb)
inverted repeat. Each repeat harbors a theta class of GST gene,
GSTT2B on the centromeric side of the repeat and GSTT2 on the
telomeric side (Figure 1A). A 37-kb deletion encompassed s the
entire centromeric side and the GSTT2B gene. We show here that
the deletion allele is very common in all three HapMap
populations. In particular, a high frequency deletion allele (66%)
in the CEU population is in linkage disequilibrium (LD) with the
neighboring GSTT1 deletion polymorphism. Such a strong LD
between deletion polymorphisms is indeed very rare within the
currently known deletion polymorphisms. The deletion has a
strong influence on the remaining GSTT2, as we found that
GSTT2 expression is severely reduced in cells with homozygous
deletion of GSTT2B. SNP analysis within the deletion region,
however, failed to yield null genotypes, possibly because almost all
these SNPs are located within a recently duplicated region.
Results
Frequent deletion polymorphism associated with a large
DNA inverted repeat
To identify structural variation in the regions of large DNA
inverted repeats (DNA-IR), we first obtained information of DNA-
IRs represented in the human genome sequence (Build 35) from
the Inverted Repeat Database (IRDB) [39]. Because of secondary
structures, perfect DNA palindromes, with small non-palindromic
spacers between arms (repeats), are predisposed to DNA
rearrangements in both simple organisms and mammals [40,41].
Therefore, we hypothesized that large DNA-IRs with high-
sequence identity between repeats and small non-palindromic
spacers may often be subject to chromosome breakage and DNA
rearrangement, and, as a result, likely to be enriched for structural
variations. Among large DNA-IRs in the human genome, one on
the chromosome 22q11.23 has a large repeat unit size (29.6-kb)
with 97.9% sequence identity between repeats, and a 2.1-kb
spacer (Figure 1A). This DNA-IR has previously been shown to be
located in the region of discordance by fosmid end-mapping and
copy number variation analyses [6,9]. Other features are also
notable in this region, such as a high frequency deletion
polymorphism (GSTT1, Figure 1A open rectangle), and a low
density of the HapMap SNPs. The gene duplicated in the DNA-
IR is GSTT2, a theta class glutathione transferase. We use the gene
name GSTT2B for the GSTT2 located on the centromeric (left)
repeat according to the annotation in the UCSC genome browser.
Molecular characterization of DNA-IRs is a challenge, because
DNA-IRs with small spacers are known to be resistant to PCR
amplification and cloning in E.coli. Southern analysis and
restriction fragment length polymorphism has been successfully
used to determine DNA structure within DNA-IRs [42]. To
identify a structural variation associated with the DNA-IR, we
designed a probe that was hybridized to the DNA near the non-
palindromic spacer. DNA rearrangements are known to occur
most frequently at the spacer and surrounding regions [43]. We
also took advantage of the segmentally duplicated sequences in this
locus. We designed a probe with high sequence homology to the
three regions (Figure 1B). By using restriction enzyme EcoRV, we
could determine genotypes for both GSTT1 and GSTT2
Author Summary
Common diseases such as cancer are caused by interac-
tions between multiple genetic and environmental factors.
Glutathione S-transferases (GST) are key enzymes in
eliminating carcinogens and harmful macromolecules from
cells. Based on the assumption that individuals who do not
have a particular type of GST genes are susceptible to
cancers, a number of studies have been conducted to find
a link between GST genotypes and cancer. However such
associations remain inconclusive to date. Because GST
genes are clustered in repetitive, complex regions in the
genome, other previously uncharacterized variations/
polymorphisms may have had an impact on the data.
We describe here such a genotype, a 37-kb deletion of
GSTT2B gene that is found very frequently among humans.
The neighboring GSTT2 gene expression is greatly
impaired by the GSTT2B deletion, conferring a potentially
null allele at GSTT2. The GSTT2B deletion is non-randomly
associated with another high frequency deletion of the
GSTT1 gene. Therefore, a detailed characterization of this
complex region of the genome revealed unexpected
genetic and biological interactions of large deletion
polymorphisms; this is essential to consider in future
disease association studies.
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PLoS Genetics | www.plosgenetics.org 2 May 2009 | Volume 5 | Issue 5 | e1000472Figure 1. Deletion polymorphisms of the GSTT2B and GSTT1 genes. A. 150-kb genomic locus harboring the GSTT2B, GSTT2 and GSTT1 genes.
Information on HapMap SNPs and known genes were obtained from UCSC genome browser. The location of a 61 kb DNA inverted repeats (indicated
by converging arrow heads) was based on the information from IRDB database. The location of GSTT2B deletion polymorphism is based on the
sequence information obtained in this study. The location of GSTT1 deletion polymorphism is based on the sequence information from Sprenger et
al. Black rectangle represents a location of the GSTT2B deletion polymorphism. Open rectangle indicates the GSTT1 deletion polymorphism. B.
Southern blotting analysis with a probe for three EcoRV fragments. Restriction map with the locations of the GSTT2B, GSTT2 and GSTT1 gene is shown.
The probe (a small rectangle) hybridized to three fragments: left repeat of the DNA-IR (6.3 kb), right repeat of the DNA IR (4.3 kb) and the fragment
near GSTT1 (16 kb). Results of Southern hybridization from 44 individuals (38 Caucasians and 6 from other populations, marked by gray circles) are
shown. Note that many individuals do not have the 6.3 kb fragment. C. Genome assembly comparison by Pipmaker. (Left), self alignment of the
137 kb genomic sequence from the NCBI Build 36.1. Coordinates are shown on the Y axis. A diagonal indicates that the same DNA sequences plotted
on the x and y-axis. Note that a large DNA inverted repeat (a crossing line to the diagonal) exists within this genomic region. (Right), Assembly
comparison between the Build 36.1 (y axis) and Celera assembly (x axis). The right half of DNA inverted repeat is missing in the Celera assembly,
which is shown as a discontinuous diagonal and a duplicated sequence present only in the Build 36.1.
doi:10.1371/journal.pgen.1000472.g001
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lymphoblastoid cell lines established from 38 Caucasian individ-
uals were used to determine the lengths of three restriction
fragments, including a 4.6-kb fragment on the telomeric (right)
repeat of the DNA-IR, a 6.3-kb fragment on the centromeric (left)
repeat, and a 16 kb fragment near the GSTT1 gene. As is shown in
Figure 1B, the 6.3 kb fragment was very frequently missing in
these samples. Nineteen samples did not have the 6.3-kb fragment,
suggesting a homozygous deletion of the right repeat of DNA-IR.
The deletion was further confirmed by using genomic DNA
digested with both SfiI and NdeI (Figure S1). In addition to the
potential homozygous deletion, there were samples that showed
reduced intensity of the 6.3 kb fragment relative to the 4.6 kb one.
These individuals could be heterozygous for the deletion.
Furthermore, the 16-kb fragments were not seen in 9 individuals,
suggesting a homozygous deletion of the GSTT1 gene. Finally, a
unique 10 kb fragment is seen in one individual (Figure 1B, star).
Southern analysis above clearly illustrated a frequent deletion
and complex pattern of structural variation within and near the
61-kb DNA-IR. To determine the extent and breakpoint of
deletion, genome assembly comparison was performed between
the NCBI Build 36 and Celera assembly (Figure 1C). To identify
differences at sequence-level resolution, we directly compared
DNA sequences by PipMaker [44]. The DNA sequences used for
this comparison cover the genomic region between MIF and
GSTT1. Self-comparison of the NCBI assembly showed a large
DNA-IR that was illustrated by a large cross-line (left) to the main
diagonal. In contrast, there was sequence discordance at the
region of the DNA-IR between two assemblies (right). Thirty-
seven kb of genomic sequences, including an entire left repeat of
the DNA-IR was missing in the Celera assembly. In fact, the
DNA-IR was not seen in the dot plot created by the self-
comparison of Celera assembly (data not shown). In order to
determine whether the frequent deletion observed by Southern
Figure 2. PCR assay for the GSTT2B and GSTT1 deletion. A. Solid lines represent genomic sequences, and rectangles represent deleted
sequences. The locations of genes (GSTT2B, GSTT2 and GSTT1) and a DNA-IR are shown. Expected PCR products are drawn as small gray bars. A PCR
assay for the GSTT2B deletion amplifies a 847 bp fragments for the non-deletion allele (middle), while a 505 bp fragment is amplified for the deletion
allele (bottom). A PCR assay for the GSTT1 deletion, developed by Strenger et al [45]., amplifies a 466 bp for non-deletion allele (middle), while a
1460 bp product is expected for deletion allele (top). A small gray triangle indicates the 408-bp repeat flanking GSTT1 deletion. Results from the two
PCR assays for 16 Caucasians are shown. B. A microhomology-mediated breakpoint. DNA sequence of the breakpoint (in the middle) is aligned with
the Build 36 (top and bottom, with each coordinates). Note that there is a two-bp microhomology at the breakpoint (in the open rectangle). Capital
letter represents sequences that are present in both assemblies.
doi:10.1371/journal.pgen.1000472.g002
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was designed to amplify a putative breakpoint (Figure 2A). This
primer set amplified the 505-bp fragment from the GSTT2B
deletion allele (del), but could not amplify a product of 39-kb
(deleted region plus franking sequence) from the non-deleted allele.
A PCR product of expected size was seen from the individuals that
show a missing or reduced intensity of a 6.3-kb fragment. DNA
sequencing of the PCR products form 5 individuals showed that
an identical breakpoint was shared among individuals. The
breakpoint resided within a unique (non-repetitive) sequence and
was mediated by 2-bp microhomology (Figure 2B). From these
results, we predicted that a GSTT2B-deleted allele exists at high
frequency in our Caucasian samples. This allele may also be a
common one in human populations, because (1) this allele is
represented in the Celera assembly and (2) the breakpoint was
identified by recent paired end-pair mappings with a small
number of samples [13,14].
Common GSTT2B deletion polymorphism is in linkage
disequilibrium with neighboring GSTT1 deletion
A 37-kb GSTT2B deletion polymorphism was located very close
to another 54-kb deletion polymorphism of GSTT1. Thus, two
large, high-frequency deletion polymorphisms exist within a
genomic region of 124 kb. CNVs are very common in the human
genome. However, neighboring, large, high frequency deletions
could be relatively rare occurrences. In order to identify whether
the deletion genotype is found at a high frequency in a large
sample population, we developed a PCR-based assay (Figure 2A).
Three primer sets were designed to simultaneously PCR-amplify
both the non-deleted (847-bp) and deleted allele (505 bp) of
GSTT2B. Similarly, previously developed PCR assay was used to
detect the GSTT1 deletion [45]. These PCR-based assays were
first applied to the genomic DNA from blood samples of the same
Caucasian population that we used for screening by Southern
analysis. To determine the robustness of our PCR-based assay to
detect the GSTT2B deletion, we genotyped these samples using
both Southern analysis and our PCR-based assay in a blinded
manner. The results obtained by both methods were then
unblended and revealed almost complete concordance (37/39
individuals). The two cases (2 individuals, 5%) of discordance
could be due to either the less accurate calling based on the
relative intensity between the 4.3- and 6.3-kb fragments by
Southern analysis, or the existence of CNV with distinct break-
points (Figure 1B, star). The frequency of the GSTT2B deletion
was very high in the population analyzed; deletion allele frequency
(0.54) was higher than that of non-deletion allele (0.46) (Table 1).
The allele frequency of the GSTT1 deletion was 0.36, which was
comparable to the frequency in the CEU population (0.39) of the
HapMap samples [5].
From the Southern analysis, we noticed a potential linkage
between the two deletion polymorphisms. Individuals who did not
have the 6.3-kb fragment tended to have the 16-kb fragment, and
individuals who did not have the 16 kb fragment tended to have
the 6.3-kb fragment. This suggests a non-random assortment
(Linkage Disequilibrium, LD) between the two deletion polymor-
phisms. In order to assess LD between the deletions, we
reconstructed deletion-based haplotypes using PHASE [46]
(Table 1). Each deletion genotype was determined based on the
results from the PCR-based assay. Haplotype frequencies at the
locus were found to be significantly deviated from the expected
values: single-gene deletions were overrepresented whereas alleles
with both gene deletions were exceedingly rare (p=5.17610
27).
The frequency of the GSTT2 deletion/GSTT1 non-deletion
haplotype was 0.49 (expected 0.34, if random) while the frequency
of the GSTT2 non-deletion/GSTT1 deletion was 0.29 (0.165, if
random). The frequency of the haplotype with both deletions was
very low, 0.048 (0.19, if random). Thus, high frequency,
neighboring deletion polymorphisms were non-randomly associ-
ated in Caucasian populations (D9=0.7719).
Extremely low GSTT2 mRNA expression with the GSTT2B
deletion
The GSTT2B deletion was not expected to have an effect on
GSTT2 expression, because the GSTT2 gene and its promoter
regions were intact in the GSTT2B-deleted allele. Gene expression
levels can be proportionate to the gene dosage in the case of exonic
deletions [5], in which case, we should expect a half level of
GSTT2 expression. Alternatively, a large genomic deletion may
influence the level of GSTT2 expression. To determine the
potential effect of GSTT2B deletion on GSTT2 expression, we
measured the GSTT2 mRNA expression level for each genotype.
GSTT2 was not expressed at an appreciable level in the
lymphoblastoid cell lines and was undetectable by Northern
analysis. Therefore, we first examined 7 cancer cell lines that
included three cell lines homozygous for the non-deletion allele
(HCT116, 2008-C13, and 2008), two heterozygous (Lovo and
Table 1. GSTT2B and GSTT1 deletion polymorphisms in 38 Caucasian individuals.
Genotype
Gene Del/Del non-del/non-del Del/Non-del HWE(p-value)
GSTT2B (n=38) 13 11 14 0.1121
GSTT1 (n=38) 6 17 15 0.4780
Population Haplotype Freq S.E D D9 Corr Chisq P-value
CEU-38-sample 0.1479 0.7719 0.6201 29.2277 6.44E-08
GSTT2B_DEL-GSTT1 0.4941 0.0093
GSTT2B_DEL-GSTT1_DEL 0.0454 0.0093
GSTT2B-GSTT1 0.1638 0.0093
GSTT2B-GSTT1_DEL 0.2967 0.0093
Freq, allele frequency; S.E., standard error; D, raw difference in frequencey between observed number and expected number; D9, scaled D spanning the range [21,1];
Corr, Correlation Coefficient; chisq, Chi-square statistics for linkage equilibrium; p-value, Chi-square p-value for marker independence.
doi:10.1371/journal.pgen.1000472.t001
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(Ovaca3 and HT29) (Figure 3A). GSTT2 expression was readily
detectable in cell lines with the GSTT2B non-deletion allele. In
contrast, in cell lines with homozygous deletions of GSTT2B,
GSTT2 expression was undetectable (Figure 3B).
Cancer cell lines are very often aneuploid, which may
contribute to the observed pattern of gene expression. We further
determined GSTT2 gene expression using 5 primary fibroblasts.
Consistent with the results from cancer cell lines, GSTT2
expression was strong in a fibroblast homozygous for the non-
deletion allele, was weaker but detectable when heterozygous, and
was undetectable in cell lines homozygous for the GSTT2B
deletion. Finally, quantitative RT-PCR analysis (Figure 3C)
showed relative gene expression levels that are very similar to
the pattern observed for null and non-null genotype; cells
homozygous for the GSTT2B deletion showed more than 80%
reduction of GSTT2 expression in cell lines homozygous for the
non-deletion alleles. Therefore, a large deletion including GSTT2B
influences the expression of a flanking gene and correlates with the
very low level of GSTT2 mRNA expression.
GSTT2B and GSTT1 deletion polymorphism as human
specific CNVs
We predicted two possible ancestral allelic states for the
GSTT2B-GSTT2 region: 1) a single GSTT2 gene that is duplicated
during the evolution of humans, or 2) an inverted duplication that
was in part deleted in the human lineage. In principle, the
ancestral allele can be inferred by analysis of the chimpanzee
genome sequence assembly (panTro2). However, we were unable
to determine the ancestral state due to the over-abundance of gaps
surrounding the chimpanzee GSTT2 assembly. Instead, we applied
molecular analyses that determined genotypes on human samples
(Figure 4). Three restriction fragments representing GSTT2B,
GSTT2 and GSTT1 in humans were all conserved in 12
chimpanzee samples, with an exception of a polymorphism seen
in the 4.6-kb fragment. The results from PCR-based assays were
also consistent with the non-deletion state of both GSTT1 and
GSTT2B in the chimpanzee. Therefore, the ancestral state is most
likely a duplicated GSTT2, where both of the deletion alleles are
derived within the human lineage.
SNP genotypes within a DNA inverted repeat
Despite its high frequency, the GSTT2B deletion polymorphism
was not detectable by systematic methods using the HapMap SNP
genotypes [1,5]; which raises the question of SNP genotypes within
the DNA-IR. HapMap SNP density is lower than average within
this locus: 37 SNPs within 124 kb in European (CEU) samples (1
SNP/3.3 kb) (Figure 1A). In order to obtain SNP genotypes within
the GSTT2B deletion polymorphism, we determined the genotype
of GSTT2B deletion in the HapMap samples (Table 2) (Table S1).
The GSTT1 deletion genotype was determined previously for the
HapMap samples [5]. The frequency of the GSTT2B deletion
allele was very high in CEU (0.63), which is consistent with that of
our Caucasian samples. The deletion polymorphism of GSTT2B
spans 7 SNPs, 6 of which are located within the duplicated
segment, while the GSTT1 deletion, which can be correctly
identified by SNP-based methods, contains 11 SNPs (Figure 5A)
(Table S2). For each sample, SNP genotypes were obtained from
the HapMap website. We expected a null genotype (N/N) in case
of homozygous deletion. In fact, this was the case for the GSTT1
deletion, in which two SNPs (rs2266633 and re5760170) were
assigned with null genotypes in more than 50% of the 15 CEU
individuals with homozygous deletion. Fifteen individuals (100%)
were genotyped as null for rs2266633, indicating excellent ‘‘SNP
tagging’’ of the GSTT1 homozygous deletion. In contrast, none of
the SNPs correctly genotyped the 39 individuals who are
homozygous for GSTT2B deletion. One SNP (rs9608219) that
was located outside of the duplicated region was called as null in 5
individuals (11.6%), while one individual was genotyped as null for
rs2330649. None of the other SNPs were genotyped as null.
Therefore, the GSTT2 deletion polymorphism status could not be
genotyped correctly by the assay used for the HapMap SNP
genotypes, which strongly suggests a difficulty of correctly
genotyping deletions located within a recently duplicated region
using SNP-based approach [19,20].
Associations between deletion polymorphisms and SNPs
differ among ancestries
The GSTT2B deletion polymorphism was also very common in
both the Japanese/Chinese populations (JCP) and the Yoruba
Figure 3. Very low level of GSTT2 mRNA expression with the
GSTT2B deletion. A. GSTT2B genotype analysis for the cancer cell lines
and primary fibroblasts used for gene expression analysis. B. Northern
blot analysis of the GSTT2 gene expression. Results from cancer cell lines
(left) and primary fibroblasts (right) are shown. Northern blot with the
human b-actin gene probe are shown as a control. Genotypes are
indicated on the top. Note that gene expression levels for cells with
homozygous deletion are very low. C. Real time PCR analysis for GSTT2
expression. Gene expression was normalized to HCT116 (for cancer cell
lines) and AG16409 (for primary fibroblasts). Relative expression level of
each cancer cell line (closed circle) and primary fibroblast (black
triangle) are shown.
doi:10.1371/journal.pgen.1000472.g003
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respectively (Table 2). Since individuals’ genotypes for GSTT1
were available, we further addressed the association between
GSTT2B and GSTT1 deletion polymorphisms in HapMap
populations. Consistent with the results from our Caucasian
samples, LD between the two deletion polymorphisms was strong
in CEU (D9=0.841), with a significant overrepresentation of
alleles with the single deletion (p=2.2610
216) (Table 2). In
contrast, LD was less evident in JCP (D9=0.60). Association of the
two deletions appears to be random in YRI (D9=0.10). In fact,
data from SNP genotypes from HapMap samples in the
surrounding region support our observations. There is a large
haplo-block including two deletions in CEU (Figure S2). Phased
haploblock analyses show that haplotypes in CEU are less diverse
than in YRI (Figure S3).
In order to determine whether the GSTT2B deletion can be
tagged by neighboring SNPs, we also assessed LD between the
deletion polymorphisms and surrounding SNPs (Figure 5B)
(Tables S3, S4, S5, S6, S7, and S8). HapMap SNP genotypes
500 kb to either side of deletions were obtained, and r
2 between
deletion polymorphisms and SNPs was calculated. LD between the
GSTT2B deletion polymorphism and SNPs were observed, and
SNPs with r
2.0.7 were identified up to 35 kb of the centromeric
side and 11 kb on the telomeric side of the deletion in all three
populations. There were several SNPs showing strong LD (r
2.0.8)
in JCP. Considering the fact that identifying SNPs showing
complete LD (r
2=1.0) with nearby CNVs is very difficult in
complex, repeat-rich regions [6,47,48], we may conclude that the
GSTT2B deletion allele is tagged by nearby SNPs and is derived
from a unique ancestral allele.
In contrast, LD between SNPs and the GSTT1 deletion
polymorphism showed a population-specific pattern. The deleted
region including GSTT1 is flanked by a pair of 466-bp direct
repeat (Figure 2A). The 51-kb region between direct repeat is
deleted in the deletion allele of GSTT1 with only one 466-bp
repeat remaining in the allele, which strongly suggests non-allelic
homologous recombination (NAHR) as an underlying mechanism.
SNPs with r
2.0.7 were identified up to 100 kb on the centromeric
side in CEU, consistent with the previous analysis [5]. In contrast,
SNPs with r
2.0.7 were less frequent and were only found within
10 kb on either side of the GSTT1 deletion in JCP. There were no
SNPs with r
2.0.7 in YRI. Therefore, the GSTT1 deletion would
be found recurrently in humans, and extended LD between SNPs
and GSTT1 deletion polymorphism in CEU may be the result of
selection forces for the haplotype harboring GSTT1 deletion.
Linkage disequilibrium between deletion polymorphisms
in the human genome
We have observed CEU-specific LD between GSTT2B and
GSTT1 deletion polymorphisms. It is currently unknown whether
closely located deletion polymorphisms are often in LD.
Answering this question is very difficult, because, although a
number of CNVs have been identified for the HapMap samples,
the breakpoints as well as the copy-numbers for each CNV have
not been well defined. Each CNV region tends to cover a large
genomic region that may include more than one CNV. This is the
case for the deletion polymorphisms for GSTT2B and GSTT1,i n
which a large single CNV region (cnp1364) covers both deletion
polymorphisms [6].
Recently, very high-density microarray has begun to provide
the locations of CNVs with higher resolution. McCarroll et al.,
have developed an extremely high-density oligonucleotide micro-
array (Affymetrix SNP 6.0) and has captured CNVs in the
HapMap samples with improved resolution [48]. Indeed, this
approach captured GSTT2B (cnp id 2559) and GSTT1 (2560)
deletion polymorphisms as independent ones. Although the
estimated size of the cnp 2559 is larger (67.1 kb, chromosome
22: 22,613,016–22,670,785) than the size from our direct
sequencing of breakpoints, a genotype result for each individual
is highly (100%) consistent with the results from PCR assay.
Therefore, the data provided by McCarroll et al., would be valid
for performing a genome-wide LD analysis.
In order to determine linkage between CNVs, we first selected
the CNVs using the following criteria: 1) we focused on the
diallelic deletion polymorphisms that are denoted as 0, 1 and 2 in
Figure 4. Characterization of GSTT2B-GSTT2-GSTT1 locus in chimpanzee. (Left), Southern analysis for eight chimpanzee cell lines. EcoRV
digested genomic DNA was hybridized with the same probe used for human samples in Figure 1B. Note that there is the same pattern of restriction
fragments in chimpanzees as in humans, with the fragments of 4.3 kb, 6.3 kb and 16 kb that correspond to the fragments representing GSTT2,
GSTT2B and GSTT1 in human respectively (Figure 1B). (Right), PCR genotyping for 12 chimpanzee samples. Non-deletion alleles for both GSTT2 and
GSTT1 were exclusively observed. PCR products from human samples were shown as examples of the deletion, heterozygous and non-deletion
genotypes.
doi:10.1371/journal.pgen.1000472.g004
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deletion polymorphisms on autosomes and excluded 16 CNVs on
sex chromosomes; and 3) we determined the linkage between
CNVs that were on the same chromosomes. There were 1857
pairs (combinations) for CEU, 1734 for JPT+CHB and 2592 for
YRI for linkage analysis, because some of the CNVs were only
seen in one or two populations.
First, we determined the number of deletion polymorphism
pairs as a function of r
2 and significance value (2log10p-value)
(Figure 6A, only for CEU). For both r
2 and significance value, the
number of pairs showed power-law distributions and the vast
majority of pairs had very low r
2 and 2log10(p-value). This
indicates that only a small number of deletion polymorphisms are
in LD. However, consistent with the result from our PCR-
genotyping, GSTT2B-GSTT1in CEU was in a strong LD
(r
2=0.699, 2log10(p-value).15 ) (Figure 6B, marked with red
circles) (Tables S9). Next, in order to determine whether strong
LD was common for closely located CNVs, we determined the r
2
and significance value as functions of physical distance (Figure 6B).
In fact, there were several, closely located deletion polymorphism
pairs with relatively high r
2 (Tables S9, S10, and S11). These pairs
were seen mostly in CEU and CHB+JPT, but not in YRI. Overall,
there was very weak association for most of the pairs, even for the
ones that are closely located. Therefore, the analysis using the
currently available list of deletion polymorphisms indicates that the
strong LD between GSTT2B and GSTT1 in CEU seems unique
and may imply the presence of selection forces in this locus.
Discussion
Deletion alleles of GST genes have been known for more than a
decade, long before we realized the global distribution and
significant impact of CNVs on genetic variation in humans.
Without knowing the major role of CNVs in genetic variation,
deletion polymorphisms of GST genes might well have been
accepted as common polymorphisms in humans but a rare event
in the human genome. Knowing now both the prevalence of
CNVs and the location of GST genes in extensive SDs, we may
need to consider a more detailed genotyping of GST genes for
disease association studies. Our approach using Restriction
Fragment Length Polymorphisms (RFLP) illustrated an overall
genetic diversity within the GSTT2-GSTT1 locus. Two major
Table 2. GSTT2B and GSTT1 deletion polymorphisms in HapMap samples.
Genotypes
Population GSTT2B_Del/GSTT2B_Del GSTT2B/GSTT2B GSTT2B_Del/GSTT2B samples (n) HWE(p-value)
CEU 25 9 26 60 0.587
JCP 26 26 37 89 0.1368
YRI 11 14 35 60 0.299
Population GSTT1_Del/GSTT1_Del GSTT1/GSTT1 GSTT1_Del/GSTT1 samples (n) HWE(p-value)
CEU 9 29 22 60 1
JCP 37 11 41 89 1
YRI 20 12 28 60 0.7926
Haplotypes
Population Haplotype Freq S.E D D9 Corr Chisq P-value
CEU (n=60) 0.1875639 0.8408842 0.79739 76.2988 ,2.2204e-16
GSTT2B_DEL-GSTT1 0.558281 0.00080
GSTT2B_DEL-
GSTT1_DEL
0.075052 0.00080
GSTT2B-GSTT1 0.050052 0.00080
GSTT2B-GSTT1_DEL 0.316614 0.00080
JCP (n=89) 0.1073 0.6061 0.4486 35.8186 2.17E-09
GSTT2B_DEL-GSTT1 0.2813 0.01228
GSTT2B_DEL-
GSTT1_DEL
0.2187 0.01228
GSTT2B-GSTT1 0.0726 0.01228
GSTT2B-GSTT1_DEL 0.4274 0.01228
YRI (n=60) 0.0235 0.1033 0.0949 1.0816 0.2983483
GSTT2B_DEL-
GSTT1_DEL
0.2564 0.01770
GSTT2B-GSTT1 0.2186 0.01770
GSTT2B-GSTT1 0.2147 0.01770
GSTT2B-GSTT1_DEL 0.3103 0.01770
Freq, allele frequency; S.E., standard error; D, raw difference in frequency between observed number and expected number.
D9, scaled D spanning the range [21,1]; Corr, Correlation Coefficient; chisq, Chisquare statistics for linkage equilibrium; p-value, Chi-square p-value for marker
independence.
doi:10.1371/journal.pgen.1000472.t002
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allele and a GSTT1-deletion allele. The GSTT2B deletion
extended for 37 kb and caused a nearly silenced expression of
the remaining GSTT2. Therefore, a null allele likely exists for both
of the theta class of GST genes in humans.
Our study revealed the high frequency of the GSTT2B deletion
alleles in all three HapMap populations, particularly in the CEU
population. This is in contrast to the neighboring GSTT1 deletion
that is the least common in Caucasians [5]. Therefore, if there are
any confounding effects of the GSTT2B deletion in the GSTT1
disease association studies, it would affect associations in
Caucasians more than in other populations. Association studies
between lung cancer susceptibility and GSTT1 deletion may
illustrate this issue. Cigarette smoke is the main environmental risk
factor for lung cancer. Cigarette smoke contains free radicals and
induces oxidative damage to cellular lipids and DNA [49]. The
theta class of GST exhibits glutathion peroxidase activity that
protects cells from oxidative damage [50]. Recent meta-analyses
show a marginal, but positive correlation between GSTT1 deletion
and lung cancer for Asians, but not for Caucasians [36,38,51]. We
Figure 5. SNP genotypes within a complex locus. A. Failed SNP genotyping in a recently duplicated segment. The locations of SNPs within the
GSTT2B deletion (red) and GSTT1 deletion (light blue) are shown. Note that most of the SNPs within the GSTT2B deletion are located in the inverted
repeat (gray lines with arrowheads). Bar diagrams indicate % of individuals homozygous for each deletion who was genotyped as null for each SNP. B.
Linkage disequilibrium (LD) of deletion polymorphisms with SNPs. LD (r
2) plots are shown for the GSTT2B (red) and GSTT1 deletion polymorphisms
(blue) in European (CEU), Japanese and Chinese (JPT+CHB), and Yoruba (YRI) populations.
doi:10.1371/journal.pgen.1000472.g005
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are not associated strongly with each other. Pairwise LD was shown for CEU population. The number of pairs (y-axis) were plotted against 2log10(p-
value) (top) and r
2 (bottom) (x-axis). B. Strong LD is uncommon between closely located deletion polymorphisms. For CEU (top), CHB+JPT (middle)
and YRI (bottom), 2log10(p-value) (left) and r
2 (right) (y-axis) are plotted against the distance between each pair of deletion polymorphisms. For each
plot, the figures for the GSTT2B-GSTT1 pair are indicated by a red circle.
doi:10.1371/journal.pgen.1000472.g006
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frequency of the GSTT1 homozygous deletion (40–60%) and lower
GSTT2B deletion in Asians may have lead to a more accurate,
positive association, whereas significant associations were difficult
to find in Caucasians due to low frequency of (10–20%) the
GSTT1 deletion and high frequency of the GSTT2B deletion.
Therefore, evaluating GSTT2B deletion polymorphism may be
necessary in order to accurately assess associations between theta
class of GST and human diseases in the future.
One of the unique features for the GSTT2B and GSTT1 deletion
polymorphisms is strong LD in the CEU population. Only a small
number of deletion polymorphisms are in LD among the currently
defined deletion polymorphisms. However, this conclusion is
preliminary, given the fact that the dataset we used has a limited
coverage on CNVs, in particular on smaller (,5 kb) ones [48].
DNA sequence level information on CNVs [13] for a large
number of individuals is necessary in order to provide an improved
list of CNV pairs with strong LD. One can do this for particular
pairs by developing a PCR assay for each CNV based on the
sequence of breakpoints and determine if there is any strong LD
between CNVs. A CNV-based assessment of LD may be useful to
complement the SNP-based approach, particularly for complex
loci. Because the density of reliable SNPs may be limited in
complex loci, a SNP-based approach may not have enough power
for reliably assessing LD.
Among other pairs of deletion polymorphisms, LD was very
strong in pairs of deletion polymorphisms that are located in peri-
centromeric regions (Tables S9, S10, and S11). Low recombina-
tion rate within peri-centromeric region [52] would contribute to
the strong LD. For example, both CNV 796 and 797 are located
within the 80 kb peri-centromeric region of the short arm of
chromosome 5. The frequencies of deletion alleles are very high in
all three populations (796 – 0.45 in CEU, 0.41 in JCP and 0.25 in
YRI; 797 – 0.45 in CEU, 0.41 in JCP and 0.25 in YRI). However,
in contrast to the GSTT2B-GSTT1 deletion polymorphism, LD is
extremely strong in all three populations (r
2; 0.999 in CEU, 0.985
in JCP and 0.955 in YRI). Deletions would occur very early in the
history of humans and have been kept in the different alleles due to
the lack of recombination. This emphasizes the uniqueness of
deletions, and may further support the history of selection in
shaping CEU-specific LD between GSTT2B-GSTT1 deletions.
A distinct pattern of LD with nearby SNPs was seen for each
deletion. The GSTT2B deletion appears to be tagged by nearby
SNPs in all three populations. In contrast, CEU-specific, extended
LD with SNPs was seen for the GSTT1 deletion. The GSTT2
deletion polymorphism most likely occurred after human-chim-
panzee divergence and the deletion allele might have been
propagating within the human linage. In contrast, linkage
equilibrium between the GSTT1 deletion and nearby SNPs in
YRI strongly suggests that the deletion including GSTT1 have
occurred recurrently in humans, possibly by NAHR between 466-
bp direct repeat. In CEU, the GSTT1 deletion is almost exclusively
seen in the allele that retains GSTT2B. Therefore, a potential
scenario could be that the GSTT1 deletion occurred in the
GSTT2B non-deletion allele and has been selected for within
CEU. The GSTT1 deletion could also be selected in JCP
population. However, because GSTT1 deletion might have
occurred recurrently in the two major alleles, the GSTT2B
deletion allele and non-deletion allele in JCP, LD with nearby
SNPs would not be as evident as in CEU.
We initiated this study on the assumption that the instability of
large DNA-IRs may be a predisposing factor for CNVs. For
example, a duplicated transgene in a 16 kb perfect palindrome
(DNA-IR) in mice was transmitted to the progeny with very high
frequency of DNA rearrangements (.15%) [53]. Typically, DNA
rearrangements occur as a deletion of a tip and part of a DNA-IR.
It was shown that nuclease processing of either a tip of hairpin
structure on the lagging-strand DNA during replication resulted in
two-ended DNA breaks [54]. Subsequent end joining may
complete the deletion process. The GSTT2B deletion includes a
part of spacer and one entire repeat, which is consistent with the
proposed mechanism. However, from our results, we do not know
whether rearrangements occur very frequently in this particular
DNA inverted repeat. The high frequency of the GSTT2B deletion
most likely comes from a unique allele propagating in humans,
because these alleles likely share an identical breakpoint. This
inverted repeat may not be as unstable as perfect DNA
palindromes due to the presence of a 2.1-kb non-palindromic
spacer and the sequence divergence (2.1%) between repeats.
However, it still is of note that there is one individual (1/44) who
has an atypical deletion (Figure 1). Therefore, overall genotypes of
the locus could be more diverse than is described here.
We found severely reduced expression of the GSTT2 gene in cell
lines with homozygous GSTT2B deletion, suggesting an influence
on neighboring gene expression [55]. Coggan et al., have shown
previously that the GSTT2B gene has a mutation at the exon 2/
intron 2 splice site that causes a premature termination at codon
196 in 28% of the Australian population. This allele was
considered as a nonfunctional pseudogene (GSTT2P) [56]. We
have also observed the same mutation in a subset of our samples
from Caucasian (9/19) and African (2/10) individuals (data not
shown). However, regardless of the functional status (GSTT2B or
GSTT2P), the presence of the second GSTT2 copy and its
surrounding region have potential functional influence over
GSTT2 expression. Position effect may explain the reduced
expression. A single functional enhancer for the pair of GSTT2(B)
genes could potentially reside in the deleted region. The deletion
would take out the single major positive control element and leave
GSTT2 inactive. Alternatively, DNA-IRs itself may have a positive
synergistic effect on gene expression. Gene amplification of a drug
resistance gene is very often initiated by inverted duplication [57].
Inverted duplications occur to counteract specific inhibitors by
increasing copy number and gene expression. Although the
unstable nature of DNA-IRs has been widely recognized, a
number of large stably maintained DNA inverted repeats in the
human genome [39] may also suggest an advantage of DNA-IRs
in biological processes, such as gene expression and DNA
replication. It is important to note that, in fibroblasts, GSTT2 is
reported as a differentially expressed gene between humans and
chimpanzees [58], with a much higher level of expression in the
chimpanzee.
In contrast to humans, chimpanzees strictly retained both
GSTT1 and GSTT2B genes in the samples tested here. Consistent
with our finding, a previous study has not identified CNVs for
these two genes in chimpanzees [59], although the study was done
using BAC-clone based array-CGH analysis with limited resolu-
tion (1 MB). Our results provide specific genes involved in a
lineage-specific CNV, which allows us to discuss history and
function of the CNV. The conserved local genomic feature (DNA-
IR) between two species, but frequent CNVs only in humans
suggests the involvement of recent selective pressure. The theta-
class is considered to be the most ancestral class of cytosolic GSTs,
and other classes, such as mu (GSTM), alpha (GSTA) and pi
(GSTP), originated from the theta class by gene duplication [33].
Importantly, unlike alpha and mu classes that have four and five
paralogues respectively, there are only two paralogues for the
theta-class, GSTT1 and GSTT2. Why then are we losing
(functionally) one of the most conserved classes of cellular
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dispensable due to the overlapping functions with other classes.
However, there are several structural features that indicate a
distinct function of the theta-class [60,61]. First, amino acid
identity between the theta-class and other classes is very low, less
than 15% in mammals. Second, the highly conserved Tyr residue,
a critical residue for glutathione (GSH) binding in other classes, is
replaced by Ser. Third, the C-terminal extension in the theta-class
proteins completely buries the substrate-binding pocket and
occludes most of the GSH-binding site. Accordingly, the
mammalian theta class lacks the ability to bind to glutathione
affinity matrices, and lacks the activity with a model substrate of
GSTs, 1-chloro-2,4-dinitrobenzene (CNDB). The least accessible
substrate-binding site may indicate a much narrower range of
substrates, which is in contrast to other classes that possess more
open, accessible substrate binding sites for a wide range of
substrates. Therefore, the compromised ability to detoxify theta-
class specific substrates in humans may be related to the difference
in phenotypes between two species [62].
In summary, we have characterized a high frequency deletion
polymorphism of GSTT2B in a complex region of the genome. We
provided a molecular approach in order to directly genotype the
GSTT2B deletion, which may be useful for future disease
association studies. These results confirm the unusual genetic
and molecular features in the regions of segmental duplications,
and the necessity of a labor-intensive approach for full under-
standing of the biology and disease phenotypes associated with
CNVs.
Materials and Methods
Samples
Peripheral-blood cells, EBV-transformed lymphoblast cell lines,
and DNA samples were collected from healthy donors [63].
Informed consent was obtained from all subjects in accordance
with procedures and protocols approved by Human Subjects
Protection Committee. HapMap DNA samples were obtained
from the Coriell Institute (http://www.coriell.org/). Sample ID
and GSTT2B genotype are listed in the Table S1.
Colorectal cancer cell lines HCT116, Lovo, HCT15, and HT29
were obtained from the ATCC. Ovarian cancer cell lines 2008
and 2008 (C13) were gift from Dr. Toshiyasu Taniguchi (Fred
Hutchinson Cancer Research Center).
Human primary fibroblasts (AG16409, AG10803, AG09319,
AG09309 and AG09429), Chimpanzee primary fibroblasts
(AG06939, S003642, S003649, S006007, S007603) and lympho-
blastoid cell lines (AG18354, AG18355, AG18356, AG18357,
AG18358, AG18359, AG16618) were obtained from the Coriell
Institute.
DNA analysis
High molecular weight genomic DNA was extracted by QIAamp
DNA Blood Midi kit (QIAGEN). Southern blotting was carried out
as described previously [64]. Two mg of high-molecular-weight
human genomic DNA were digested with a restriction enzyme,
separated in 0.8% agarose gels. The gel was transferred to a
positively charged nylon membrane (Amersham Biosciences) for 3 h
at 75–80 mmHg pressure using the PosiBlot 30–30 pressure blotter
and pressure control station (Stratagene). The DNA was UV-
crosslinked to the nylon membrane using the Stratalinker 1800 UV
crosslinker (Stratagene). To make a probe for Southern-blot analysis,
we amplified human genomic DNA using PCR primers IR28-
26352F, 59-CAAGAGGCTACACAGGCAGATGTC-39,I R 2 8 -
26980R 59-GGGCAGAGGAACGGAAACA-39, and cloned the
fragment by TOPO TA Cloning Kit (Invitrogen).
In order to genotype the GSTT2B deletion, a three primer set
was designed for PCR: GSTT2B-6858, 59-CACTCAACACAG-
TAGCCTCATCGTG-39, GSTT2B-6857, 59
TGCCTCCCCTGCCTTATTTC 39, and GSTT2B-2B, 59-
CCTTCTGAAATGGAGCCTTTG-39. The reaction was per-
formed in a duplex-PCR with a final volume of 50 ml with 1.0 U
Taq polymerase (GoTaq, Promega), 1.5 mM MgCl2, 200 mM
dNTPs, 10 pmol of each primer, and 50 ng of genomic DNA. The
thermal cycling conditions used for amplification consisted of an
initial denaturation step at 95uC for 2 min, followed by 30 cycles
of denaturation at 95uC for 30 s, annealing at 60uC for 30 s, and
extension at 72uC for 45 s. Duplex PCR analysis for GSTT1 was
performed using the four primers as previously reported [45]. The
reaction was performed in the final volume of 25 ml with 0.4 U of
Faststart Taq polymerase, GC rich solution (Roche, USA), 2 mM
MgCl2, 800 mM dNTPs, 10 pmol of each oligonucleotide primer,
and 50 ng of genomic DNA. Thermal-cycling conditions consisted
of an initial denaturation step at 95uC for 7 min, followed by 30
cycles of denaturation at 95uC for 30 s, annealing at 60uC for 30 s,
and extension at 72uC for 60 s, and final extension at 72uC for
7 min.
Automated sequencing was performed directly both on the gel-
purified PCR products and the PCR product cloned into TOPO
TA cloning kit (Invitrogene, USA).
mRNA analysis
Total RNA was extracted from cells using the RNeasy Kit
(Qiagen). Ten mg of total RNA was loaded onto a 0.9% agarose-
formaldehyde gel and separated for 60 min at 100 V. RNA
quality was assessed by the integrity of 28S and 18S. The gel was
transferred to a positively charged nylon membrane (Amersham
Biosciences) for 3 h at 75–80 mmHg pressure using the PosiBlot
30–30 pressure blotter and pressure control station (Stratagene).
The RNA was UV-crosslinked to the nylon membrane using the
Stratalinker 1800 UV crosslinker (Stratagene). Each membrane
was probed for both GSTT2 and b-actin. Both probes were PCR
amplified and cleaned using the Gel Extraction Kit (Qiagen).
Primers for the GSTT2 cDNA are GSTT2 cDNA 31F – 59-
AGAGCTGTTTCTTGACCTGGTGTC-39, GSTT2 cDNA
938R – 59-GGTTATGTATGCTGCACCTGAGG-39. Each
probe was labeled with [a-
32P]dATP (3000 Ci/mmol; Perkin
Elmer). Membranes were hybridized overnight at 65uCi n
modified Church Buffer (0.5 M sodium phosphate, pH 7.2, 7%
SDS, 10 mM EDTA) and exposed to Kodak BioMax MS film
(Kodak). After probing for GSTT2, membranes were stripped at
65uC for 2 h in 0.5% SDS and reprobed for b-actin to verify equal
amounts of RNA in each lane.
1t o2 mg of RNA was reverse transcribed using the
Superscript First-Strand Synthesis kit (Invitrogen) according to
the manufacturer’s conditions. The real time PCR was carried
out using a MiniOpticon Real Time PCR Detection System (Bio-
Rad). The PCR reaction contained 50 ng/ml of cDNA, 10 pmol
of each of the specific primer sets for GSTT2 and RPL32, 6.25 ml
of iQ SYBR Green Supermix (Bio-Rad) master mixture (26mix
containing 50 U/ml iTaq DNA polymerase, 6 mM MgCl2,
SYBR Green I, dNTP mix, 20 nM fluorescein and stabilizers) in
a final reaction volume of 13 ml. All reactions were performed in
triplicate. Thermalcycling conditions for GSTT2 consisted of an
initial denaturation of 10 min at 95uC, 40 cycles of 15 s at 95uC
denaturing and 1 min at 55uC annealing and a final extension
step for 10 min at 72uC. Cumulative fluorescence was measured
at the end of each of the 40 cycles. For RPL32, thermalcycling
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95uC, followed by 40 cycles of 15 s at 95uC denaturing and
1 min at 60uC annealing. Cumulative fluorescence was measured
after each of the 40 cycles. Product specific amplification was
confirmed by melting curve analysis. Primers used for quantifi-
cation were as follows: GSTT2, forward, 59-CGCTCAAG-
GATGGTGATTTC-39 and reverse, 59-AGGTACTCATGAA-
CACGGGC-39; RPL32, forward, 59-
GCCAGATCTTGATGCCCAAC-39 and reverse, 59-
CGTGCACATGAGCTGCCTAC-39. Relative quantification of
GSTT2 gene expression was determined by construction of a
relative expression calibration curve using serial dilutions of a
positive control.
SNPs and LD analysis
The SNP genotypes used in this work were downloaded from
HapMap Public Release #23a (2008-04-01). SNP genotypes were
obtained for 500 kb regions to either side of deletions. GSTT1
deletion genotypes for HapMap samples were obtained from the
previous publication [5]. Haplotypes were determined using Phase
2.1 [46]. Hardy-Weinberg Equilibrium tests (HWE test), pairwise-
r
2 value, D and D9, Chi-square p-value for marker independence
were computed using R (genetics package).
Association between CNVs was determined using the data by
McCarroll et al. [48]. In this dataset, the locations of CNVs as well
as genotypes of HapMap individuals were available. In this
analysis, associations between deletion polymorphisms that are on
the same autosomes were determined. For the 1857 pairs
(combinations of deletion polymorphisms) for CEU, 1734 for
JPT+CHB and 2592 for YRI, pairwise-r
2 value, D and D9, Chi-
square p-value and Hardy-Weinberg Equilibrium tests (HWE test)
were computed using R (genetics package). In order to determine
the distance between two deletion polymorphisms, we used a
formula, (|S1–S2|+|E1–E2|)/2, where S1 and S2 represent the
start sites (hg18) of the CNVs and E1and E2 represent the end sites
of the CNVs. Chi-square p-value and r
2 was plotted as a function
of distance.
Web resources
UCSC genome Browser, http://genome.ucsc.edu/
PipMaker and MultiPipMaker, http://pipmaker.bx.psu.edu/
pipmaker/
The R Project for Statistical Computing, http://www.r-project.
org/
PHASE: software for haplotype reconstruction, and recombi-
nation rate estimation from population data, http://stephenslab.
uchicago.edu/software.html
Supporting Information
Figure S1 Southern blotting analysis with a probe for three
SfiI+NdeI fragments. Restriction map with the locations of the
GSTT2B, GSTT2 and GSTT1 gene is shown. The probe (a small
rectangle) hybridized to three fragments: left repeat of the DNA-
IR (11.3 kb), right repeat of the DNA IR (9.7 kb) and the fragment
near GSTT1 (21 kb). Genomic DNA from 14 individuals (also
shown in the Figure 1B, right panel) are shown. While a 9.7 kb
fragments (corresponding to GSTT2) are retained in all individuals,
a 11.3 kb fragment (corresponding to GSTT2B) are seen in 5
individuals.
Found at: doi:10.1371/journal.pgen.1000472.s001 (1.96 MB EPS)
Figure S2 Haploblocks for three populations (from HapMap
website).
Found at: doi:10.1371/journal.pgen.1000472.s002 (4.74 MB EPS)
Figure S3 Phased Haplotype for three populations (from
HapMap website).
Found at: doi:10.1371/journal.pgen.1000472.s003 (1.65 MB EPS)
Table S1 GSTT2B deletion genotypes (HapMap).
Found at: doi:10.1371/journal.pgen.1000472.s004 (0.04 MB
XLS)
Table S2 Deletion (GSTT2B and GSTT1) and SNP genotypes
(HapMap CEU).
Found at: doi:10.1371/journal.pgen.1000472.s005 (1.95 MB
XLS)
Table S3 Linkage analysis between GSTT2B deletion and SNP
(CEU).
Found at: doi:10.1371/journal.pgen.1000472.s006 (0.09 MB
XLS)
Table S4 Linkage analysis between GSTT1 deletion and SNP
(CEU).
Found at: doi:10.1371/journal.pgen.1000472.s007 (0.41 MB
XLS)
Table S5 Linkage analysis between GSTT2B deletion and SNP
(JCP).
Found at: doi:10.1371/journal.pgen.1000472.s008 (0.16 MB
XLS)
Table S6 Linkage analysis between GSTT1 deletion and SNP
(JCP).
Found at: doi:10.1371/journal.pgen.1000472.s009 (0.16 MB
XLS)
Table S7 Linkage analysis between GSTT2B deletion and SNP
(YRI).
Found at: doi:10.1371/journal.pgen.1000472.s010 (0.45 MB
XLS)
Table S8 Linkage analysis between GSTT1 deletion and SNP
(YRI).
Found at: doi:10.1371/journal.pgen.1000472.s011 (0.17 MB
XLS)
Table S9 Linkage analyses between deletion polymorphisms
(CEU).
Found at: doi:10.1371/journal.pgen.1000472.s012 (0.18 MB
XLS)
Table S10 Linkage analysis between deletion polymorphisms
(JCP).
Found at: doi:10.1371/journal.pgen.1000472.s013 (0.16 MB
XLS)
Table S11 Linkage analysis between deletion polymorphisms
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